APA

Andersen N. J., Nickoloff B. J., Dykema K. J., Boguslawski E. A., Krivochenitser R. I., Froman R. E., Dawes M. J., Baker L. H., Thomas D. G., Kamstock D. A., Kitchell B. E., Furge K. A. & Duesbery N. S. (20140401). Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma. : Molecular cancer therapeutics.

Chicago

Andersen Nicholas J, Nickoloff Brian J, Dykema Karl J, Boguslawski Elissa A, Krivochenitser Roman I, Froman Roe E, Dawes Michelle J, Baker Laurence H, Thomas Dafydd G, Kamstock Debra A, Kitchell Barbara E, Furge Kyle A and Duesbery Nicholas S. 20140401. Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma. : Molecular cancer therapeutics.

Harvard

Andersen N. J., Nickoloff B. J., Dykema K. J., Boguslawski E. A., Krivochenitser R. I., Froman R. E., Dawes M. J., Baker L. H., Thomas D. G., Kamstock D. A., Kitchell B. E., Furge K. A. and Duesbery N. S. (20140401). Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma. : Molecular cancer therapeutics.

MLA

Andersen Nicholas J, Nickoloff Brian J, Dykema Karl J, Boguslawski Elissa A, Krivochenitser Roman I, Froman Roe E, Dawes Michelle J, Baker Laurence H, Thomas Dafydd G, Kamstock Debra A, Kitchell Barbara E, Furge Kyle A and Duesbery Nicholas S. Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma. : Molecular cancer therapeutics. 20140401.